Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

ABSTRACT: Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

PROVIDER: PRJNA551582 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9610550.fastq.gz	Fastqsanger.gz
	SRR9610551.fastq.gz	Fastqsanger.gz
	SRR9610546.fastq.gz	Fastqsanger.gz
	SRR9610547.fastq.gz	Fastqsanger.gz
	SRR9610548.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

Project description:Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

| PRJNA551658 | ENA

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

Project description:Many current cellular models aimed to elucidate cancer biology do not recapitulate pathobiology including tumor heterogeneity, an inherent feature of cancer that underlies treatment resistance. Here we introduce a new cancer modeling paradigm using genetically engineered human pluripotent stem cells (hiPSCs) that capture authentic cancer pathobiology. Orthotopic engraftment of the neural progenitor cells derived from hiPSCs introduced with tumor-associated genetic driver mutations revealed by The Cancer Genome Atlas project for glioblastoma (GBM) results in formation of brain tumors. As observed in GBM patient samples, these models harbor inter-tumor heterogeneity resembling different GBM molecular subtypes, and intra-tumor heterogeneity. Further, re-engraftment of these tumor cells generate tumors with features characteristic of patient samples and present mutation-dependent patterns of tumor evolution. Thus, these cancer avatar models provide a platform for a comprehensive longitudinal assessment of human tumor development as governed by molecular subtype mutations.

2019-12-10 | GSE133479 | GEO

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

2019-12-10 | GSE133509 | GEO

RNA-seq of genetically engineered mouse microglia

Project description:RNA-seq of genetically engineered mouse microglia sorted into populations.

2022-04-06 | GSE196174 | GEO

RNA-seq of genetically engineered mouse microglia

Project description:RNA-seq of genetically engineered mouse microglia

| PRJNA803528 | ENA

Francisella tularensis subsp. tularensis strain:genetically engineered

Project description:Francisella tularensis subsp. tularensis strain:genetically engineered Genome sequencing

| PRJNA1040318 | ENA

A genetically engineered mouse model of NUT carcinoma

Project description:A genetically engineered mouse model of NUT carcinoma

| PRJNA1008241 | ENA

RNAseq of genetically engineered mouse model (GEMM) tumors

Project description:We report the expression profiling of lung adenocarcinoma tumors arising from genetically engineered mice with activation of KRAS(K) and loss of either SMARCA4 (S), p53(P) or both.

2018-06-17 | GSE94927 | GEO

Genetically engineered endothelial niche induces vascularization in human kidney organoids

Project description:Here we developed a method to incorporate a genetically engineered endothelial niche into an established protocol for generating human kidney organoids.

2023-05-22 | GSE232767 | GEO

Modeling melanoma resistance in a genetically engineered mouse model

Project description:Modeling melanoma resistance in a genetically engineered mouse model

| PRJNA650202 | ENA